![Jack Higgins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Higgins
Direttore Tecnico/Scientifico/R&S presso
IMMUNOME, INC.
Patrimonio netto: 545 750 $ in data 31/05/2026
Profilo
Jack Higgins currently works at Immunome, Inc., as Chief Scientific Officer from 2023.
Dr. Higgins also formerly worked at Molecular Templates, Inc., as Chief Development Sciences Officer, Molecular Templates, Inc., as Chief Development Sciences Officer from 2019 to 2021, and MorphImmune, Inc., as Chief Scientific Officer from 2022 to 2023.
Dr. Higgins received his undergraduate degree from Texas A&M University and graduate degree and doctorate degree from The University of Arkansas.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOME, INC. 0,02% | 02/04/2026 | 25.000 ( 0,02% ) | 545 750 $ | 31/05/2026 |
Posizioni attive di Jack Higgins
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOME, INC. | Direttore Tecnico/Scientifico/R&S | 02/10/2023 |
Precedenti posizioni note di Jack Higgins
| Società | Posizione | Fine |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Direttore Tecnico/Scientifico/R&S | 01/10/2023 |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Direttore operativo | 01/06/2019 |
| MOLECULAR TEMPLATES, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jack Higgins
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
8
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
